Prostanozol
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| Identifiers | |
| |
| Synonyms | 17α-Demethylstanozolol 17β-tetrahydropyran ether; 17β-Hydroxy-5α-androstano[3,2-c]pyrazole 17β-tetrahydropyran ether; [3,2-c]Pyrazole-5α-etioallocholane-17β-tetrahydropyranol |
| CAS Number | 1186001-41-1 |
| PubChem (CID) | 56842253 |
| ChemSpider |
32700007  |
| UNII |
JNU1579M5D |
| Chemical and physical data | |
| Formula | C25H38N2O2 |
| Molar mass | 398.580 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| (verify) | |
Prostanozol, also known as demethylstanozolol tetrahydropyran ether, is an androgenic-anabolic steroid (AAS) and designer steroid which acts as a prodrug of the 17α-demethylated analogue of stanozolol (Winstrol). It was found in 2005 as an ingredient of products sold as "dietary supplements" for bodybuilding.[1]
It is one of hundreds of drugs banned from the Olympics by the IOC.[2] Russian marathon runner Lyubov Denisova was banned for two years from competition after testing positive for prostanozol and testosterone in 2007.[3]
References
- ↑ Eenoo PV, Delbeke FT. Metabolism and excretion of anabolic steroids in doping control—New steroids and new insights. Journal of Steroid Biochemistry and Molecular Biology. 2006;101(4-5):161-178. doi:10.1016/j.jsbmb.2006.06.024
- ↑ "192 Banned Performance Enhancing Substances and Methods". ProCon.org. March 17, 2010. Retrieved July 25, 2015.
- ↑ "Russian marathon runner Denisova banned for 2 years for doping". USA Today. May 15, 2007. Retrieved July 25, 2015.
This article is issued from Wikipedia - version of the 12/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.